La cadena de opciones muestra datos clave de las opciones de acciones de Lisata Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Lisata Therapeutics..

Lisata Therapeutics (NASDAQ:LSTA) Bolsa, Cadena de Opciones

Lisata Therapeutics

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ANAB

ASST

CCLD

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

DWTX

HSDT

HUBC

LSTA

NEHC

NFLX

SEPN

STFS

USEG

Netflix sorprende con un aumento en suscriptores y mejores pronósticos. Descubre también los mayores ganadores y perdedores del premercado.

Acciones de Netflix se disparan alrededor del 15%; 20 acciones que se están moviendo en el premercado de EE.UU.

Lisata Therapeutics Inc

Ask 10 people what it takes to be <a href="https://www.benzinga.com/25/03/44131089/kevin-oleary-says-making-1-million-is-almost-impossible-but-getting-to-5-million-is-surprisingly-easier">financially set for life</a>, and most will throw out numbers with lots of commas: $5 million, $10 million, maybe more if they're feeling pessimistic about inflation and avocado prices. But Kevin O'Leary, entrepreneur and "Shark Tank" mainstay, says the real magic number isn't in the millions. It's $500,000.
In a <a href="https://youtube.com/shorts/TcpVd9VmE7M?si=oahf9HaAfL1BgPEU">2023 YouTube short</a>, O'Leary tackled the question head-on: How much do you need to live a comfortable or wealthy life? His answer? That depends on your lifestyle. But for many people, he says, half a million bucks in the bank can do the trick.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>
"It's all about lifestyle," he says in the clip. "You can live off half a million bucks in the bank and do nothing else to make money."
Sounds too good to be true? It depends on what you do with that money and more importantly, what you don't do with it.
O'Leary explains if you're investing wisely, you could reasonably earn around 5% annually in fixed income with "very little risk." That's $25,000 a year without touching your principal — enough to cover modest living expenses, especially if you own your home and live in a low-cost area. Want to push that income a little higher? According to O'Leary, you could aim for 8.5% to 9% returns by mixing in equities, if you're willing to "ride the volatility."
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
That added risk comes with potential reward but also potential stress. The market doesn't always cooperate, and while equities historically trend upward, there's no guarantee they'll behave when you need them to. If the idea of watching your <a href="https://www.benzinga.com/personal-finance/25/03/44316684/warren-buffett-said-bad-news-is-an-investors-best-friend-and-if-youre-not-ready-for-stocks-to-drop-50-you-shouldnt-be-investing">portfolio dip during a downturn</a> sends your blood pressure soaring, you might want to stick with the slower but steadier option.
But O'Leary isn't just handing out ideas — he's got strong feelings about what not to do.
"Do not invest in your brother's restaurant or a bowling alley or a bar," he warns. "Or all that other crap. You'll lose your money on that."
Point taken.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
Still, his $500,000 plan isn't for everyone. Even at a 6% return, that's $30,000 a year — not exactly luxury living, especially with rising medical costs, rent, and a grocery bill that seems to laugh at budgets.&nbsp;
Even with higher returns near 9%, you'd be working with about $45,000 a year — enough to get by, but probably not enough to quit your job unless your house is paid off, you have no debt, and you live a lean, frugal lifestyle. O'Leary did say it all comes down to <a href="https://www.benzinga.com/personal-finance/25/02/43539942/are-you-rich-heres-what-americans-think-you-need-to-be-considered-wealthy-2">your standard of living</a>, but for most people, living comfortably on that setup would require a serious commitment to keeping expenses low.
O'Leary's advice is simple, direct, and depending on your lifestyle…surprisingly doable. But his real point might be this: the path to financial freedom isn't always paved with millions. Sometimes, it's about knowing what you want, avoiding bad investments, and <a href="https://www.benzinga.com/personal-finance/25/02/43759618/charlie-munger-said-the-hardest-part-of-getting-rich-is-the-first-100000-but-from-there-it-snowballs-and-you-can-ease-off-the-gas">letting compound interest do the heavy lifting</a>.
Read Next:
<ul>
<li>With shares starting at $1.52, <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">this could be your chance to invest in the future of healthcare</a>.</li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>
Image: Shutterstock

Personal Finance

Kevin O'Leary Says $500,000 Is The Magic Number To Live Comfortably — 'You Can Live Off Half A Million Bucks And Do Nothing Else To Make Money'

argenx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) has outperformed the market over the past 5 years by 18.91% on an annualized basis producing an average annual return of 32.94%. Currently, argenx has a market capitalization of $36.40 billion. 
Buying $1000 In ARGX: If an investor had bought $1000 of ARGX stock 5 years ago, it would be worth $4,066.85 today based on a price of $596.20 for ARGX at the time of writing.
<h3>argenx's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745008224_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARGX

Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 36.99% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed up 23.33% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/MRMD">MariMed</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTC">MRMD</a>) shares closed up 20.10% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed up 16.33% at $0.98</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 12.50% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed up 8.74% at $0.67</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Indus</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed up 7.69% at $5.60</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 4.92% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/SMG">Scotts Miracle Gro</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) shares closed up 4.74% at $52.17</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 4.66% at $1.54</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Glb Inv</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 4.43% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/SOL">Emeren Group</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 4.24% at $1.26</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 3.85% at $0.91</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed up 3.70% at $1.40</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 3.45% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 3.39% at $1.19</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 3.39% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed up 3.38% at $0.46</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 3.21% at $4.44</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed down 73.33% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 46.39% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed down 10.63% at $0.57</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 7.19% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed down 6.17% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 4.91% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 4.68% at $0.06</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed down 4.67% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 4.60% at $0.45</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 3.75% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 3.72% at $6.03</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

BBRRF

BLOZF

CLSH

CNTMF

CRBP

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CVSI

CXXIF

ELLXF

FFNTF

FUAPF

GRWG

GTBIF

KAYS

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

MRMD

NWVCF

OILFF

RMHB

SNDL

SOLCF

TGIFF

TLRY

UGRO

Marijuana Stock Movers For April 18, 2025

Option Care Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPCH#NASDAQ">OPCH</a>) has outperformed the market over the past 5 years by 7.32% on an annualized basis producing an average annual return of 21.35%. Currently, Option Care Health has a market capitalization of $5.29 billion. 
Buying $1000 In OPCH: If an investor had bought $1000 of OPCH stock 5 years ago, it would be worth $2,601.14 today based on a price of $32.02 for OPCH at the time of writing.
<h3>Option Care Health's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745007314_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

OPCH

Here's How Much You Would Have Made Owning Option Care Health Stock In The Last 5 Years

Author&nbsp;Robert Kiyosaki&nbsp;cautioned about the potential for significant job losses in the near future. He urged individuals to pivot towards entrepreneurship and bolster their financial education.
What Happened: In a post on X, Kiyosaki voiced his apprehensions about the evolving job market on April 16. He highlighted the millions of jobs lost in the past two years and projected that the trend will continue, affecting millions more.
Seizing this moment, Kiyosaki advised individuals to shift their attention from job security to entrepreneurship. He proposed that&nbsp;joining a network marketing company&nbsp;could be a cost-effective way to develop entrepreneurial skills. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">BEFORE YOU LOSE YOUR JOB In the last two years…. Millions have lost their jobs. In the next few years…. Millions more will lose their jobs. If you are feeling you may lose your job….best prepare now. Turn a bad event to a great opportunity to stop being an employee,…
&mdash; Robert Kiyosaki (@theRealKiyosaki) <a href="https://twitter.com/theRealKiyosaki/status/1912508493338157069?ref_src=twsrc%5Etfw">April 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Despite potential challenges, such as high rejection rates and unstable income, Kiyosaki views this as a feasible option for those at risk of unemployment.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44550875/robert-kiyosaki-thinks-saving-in-cash-is-a-bad-idea-heres-why">Robert Kiyosaki Thinks Saving in Cash Is a Bad Idea. Here&#8217;s Why.</a>
Kiyosaki has been a consistent voice warning about economic downturns and the devaluation of the U.S. dollar. 
He is a staunch supporter&nbsp;of assets like Bitcoin, gold,&nbsp;and silver and continues to stress the significance of financial education and taking proactive measures towards financial&nbsp;independence in an unpredictable economy.
Why It Matters: Kiyosaki&#8217;s warning comes at a time when the global economy is still grappling with the effects of the COVID-19 pandemic. His advice to focus on entrepreneurship and financial education is particularly relevant as traditional job markets continue to evolve and become more uncertain. 
His endorsement of network marketing companies as a means to gain entrepreneurial skills could potentially influence many to consider this path. 
Furthermore, his advocacy for&nbsp;assets like bitcoin, gold, and&nbsp;silver underscores the growing interest in alternative investment avenues amidst economic instability.
Read Next
<a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43901226/robert-kiyosaki-says-everything-bubble-will-cause-historic-market-crash-bitcoin-will-be-fastest-to-recover" target="_blank" rel="noreferrer noopener">Robert Kiyosaki Says ‘Everything Bubble' Will Cause Historic Market Crash, Bitcoin Will Be Fastest To Recover</a>
Image: Shutterstock/Grower C More

Politics

Robert Kiyosaki Says Millions Could Be Out of Work — Here's His Game Plan

Looking into the current session, MasTec Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTZ#NYSE">MTZ</a>) shares are trading at $117.37, after a 0.03% decrease. Over the past month, the stock decreased by 6.18%, but over the past year, it actually went up by 38.92%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1745006438_0.png" alt="Past Year Chart" />

<h3>Comparing MasTec P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
MasTec has a better P/E ratio of 57.0 than the aggregate P/E ratio of 35.39 of the Construction &amp; Engineering industry. Ideally, one might believe that MasTec Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1745006438_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

P/E Ratio Insights for MasTec

Wells Fargo's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) short percent of float has fallen 16.51% since its last report. The company recently reported that it has 29.71 million shares sold short, which is 0.91% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.15 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Wells Fargo Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745006431_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Wells Fargo has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Wells Fargo's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Wells Fargo's peer group average for short interest as a percentage of float is 1.11%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Is Wells Fargo Gaining or Losing Market Support?

Carpenter Tech's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) short percent of float has fallen 7.56% since its last report. The company recently reported that it has 3.36 million shares sold short, which is 9.41% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.46 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Carpenter Tech Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745006426_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Carpenter Tech has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Carpenter Tech's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Carpenter Tech's peer group average for short interest as a percentage of float is 5.54%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Carpenter Tech?

MongoDB's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NYSE">MDB</a>) short percent of float has risen 20.98% since its last report. The company recently reported that it has 3.68 million shares sold short, which is 4.67% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.04 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>MongoDB Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745006421_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for MongoDB has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing MongoDB's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, MongoDB's peer group average for short interest as a percentage of float is 7.79%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Do Investors Really Feel About MongoDB?

GoDaddy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDDY#NYSE">GDDY</a>) has outperformed the market over the past 5 years by 7.65% on an annualized basis producing an average annual return of 21.68%. Currently, GoDaddy has a market capitalization of $24.28 billion. 
Buying $100 In GDDY: If an investor had bought $100 of GDDY stock 5 years ago, it would be worth $255.78 today based on a price of $171.78 for GDDY at the time of writing.
<h3>GoDaddy's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745006414_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GDDY

Here's How Much $100 Invested In GoDaddy 5 Years Ago Would Be Worth Today

President Donald Trump expressed his hesitation to escalate tariffs on China, citing potential trade stagnation. He also hinted at China&#8217;s attempts to negotiate a deal.
What Happened: Trump voiced his concerns about escalating tariffs on China, suggesting it could hinder trade between the two nations. He also mentioned that Beijing has made several attempts to initiate talks.
Trump avoided direct answers when questioned about his personal contact with Chinese leader&nbsp;Xi Jinping. He emphasized his good relationship with Xi and suggested that any outreach from China would have Xi&#8217;s knowledge and approval, <a href="https://www.bloomberg.com/news/articles/2025-04-17/trump-says-he-is-reluctant-to-keep-raising-tariffs-on-china?srnd=homepage-americas&amp;sref=TBDibEcD">reports </a>Bloomberg. 
The ongoing economic clash between the US and China has seen both countries imposing hefty import duties on each other. Trump has increased&nbsp;levies to a combined 145%&nbsp;on Chinese goods, with China retaliating&nbsp;with duties of 125% on&nbsp;US goods.
Also Read: <a href="https://www.benzinga.com/news/25/04/44778488/as-trump-intensifies-tariff-war-with-china-global-economy-feels-the-tremors-whats-the-endgame-here">As Trump Intensifies Tariff War With China, Global Economy Feels the Tremors: &#8216;What&#8217;s the Endgame Here?&#8217;</a>
Despite the high tariff levels, Trump indicated a potential willingness to lower them. He also&nbsp;expressed confidence about a deal&nbsp;that would include trade concessions&nbsp;and a deal for the&nbsp;sale of TikTok&#8217;s US assets.
Trump suggested that the discussion of tariffs could be a part of the negotiation if China approves ByteDance Ltd.&#8217;s divestment of TikTok&#8217;s US operations.
Why It Matters: The trade war between the US and China has been a significant factor in global economic dynamics. The high tariffs imposed by both countries have affected global trade patterns and have the potential to stagnate trade between the two nations. 
Trump&#8217;s reluctance to further escalate tariffs and his hint at a potential trade deal could signal a shift in US-China trade relations. This development could have significant implications for global trade and economic stability.
Read Next
<a href="https://www.benzinga.com/news/25/04/44658808/scaramucci-on-tariffs-there-is-stupid-and-then-there-is-donald-trump-stupid" target="_blank" rel="noreferrer noopener">Scaramucci on Tariffs: ‘There Is Stupid and Then There Is Donald Trump Stupid'</a>
Image: Shutterstock

Trump Expresses Reluctance To Escalate China Tariffs, Hints At Trade Deal

Did you know that $2.7 trillion in commercial debt is maturing in the next 30 months? This event can have <a href="https://www.tiktok.com/@grantcardone/video/7492144240714108203?lang=en">significant ramifications</a> on the global economy, and Grant Cardone doesn't mince words when he says what can happen.
"The problem is so big, it can drag down 300 banks," the real estate investor and author of "The 10X Rule" stated.
Is the claim overblown hyperbole, or is it justified for investors to be worried about the looming debt? These are some of the details to consider.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
<h2 class="wp-block-heading">Office Space Is Losing Demand</h2>
While Cardone also mentioned apartment buildings, he put most of the focus on office space when describing the looming $2.7 trillion debt. Commercial real estate isn't doing as well because people got comfortable with remote work during the pandemic. Many companies now offer hybrid work or fully remote work, and that reduces the demand for office space.
Fewer tenants and less demand translate into lower rents and vacant units. That's not good for landlords, and it can lead to loan defaults. An asset class that is losing value will only get worse if foreclosures become more common. Cardone mentions that regional banks can feel the most pressure since commercial real estate makes up a large portion of their books.
He believes that more than 300 banks can go out of business. Cardone also mentioned that government pension funds can also go bust once commercial real estate prices crash.
Trending: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
<h2 class="wp-block-heading">Leverage Is A Double-Edged Sword</h2>
The looming commercial real estate crisis highlights the risk of leverage. While you can generate passive cash flow and have your tenants cover your mortgage, conditions can change quickly and leave investors in vulnerable positions.
Lately, Cardone has been using cash to finance his deals. He's said that he's waiting for interest rates to get lower before borrowing against his properties. While buying a rental property with 3% down may sound attractive to a real estate investor who wants to quickly scale their portfolio, there are significant risks with this approach.
Over-leverage combined with a declining demand for commercial real estate can put a lot of pressure on financial institutions. Office space in big cities like Boston and San Francisco is also facing downward pressure that can affect how those cities generate tax revenue.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
<h2 class="wp-block-heading">Long-Term Headwinds Can Make It Worse</h2>
While some locations have more insulation than others, the outlook doesn't suggest a V-shaped recovery for commercial real estate. Cardone mentioned that some commercial real estate properties are selling for 10 cents on the dollar. While that may only apply to a small portion of real estate properties, a Redditor compiled a <a href="https://www.reddit.com/r/CommercialRealEstate/comments/1fuiwi5/more_bloodbath_in_the_san_francisco_office_space/">list of recent San Francisco commercial property sales</a> that are hard to ignore.&nbsp;
The first example is pretty close to Cardone's claim of commercial properties selling for 10 cents on the dollar. Most of the properties on the list have lost 50% to 80% of their value within a decade.
Vacancy rates may continue to drop as remote and hybrid work become normalized. Apartments may also face some heat due to deportations increasing the housing supply and low fertility rates continuing to fuel the trend of new retirees outnumbering new workers.&nbsp;
Although long-term headwinds remain, Trump's tariffs can benefit the industry by forcing the Fed to lower interest rates. Near-zero interest rates would make it easier for investors to refinance their commercial real estate loans. This approach would kick the can further down the road, but Cardone's warning about a $2.7 trillion commercial real estate collapse holds a lot of merit.
Read Next:
<ul>
<li>With shares starting at $1.52, <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">this could be your chance to invest in the future of healthcare</a>.</li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Grant Cardone Explains How The $2.7 Trillion Debt Crisis Can Blow Up The Economy: 'The Problem Is So Big It Can Drag Down 300 Banks'

Planet Fitness's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>) short percent of float has fallen 6.0% since its last report. The company recently reported that it has 5.65 million shares sold short, which is 7.68% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.58 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Planet Fitness Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745002866_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Planet Fitness has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Planet Fitness's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Planet Fitness's peer group average for short interest as a percentage of float is 15.01%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

PLNT

How Do Investors Really Feel About Planet Fitness?

Wall Street wrapped up a shortened trading week ahead of the Easter holiday in the red, weighed down by fresh export restrictions on chips to China that sent tech <a href="https://www.benzinga.com/topic/chipmakers">and semiconductor stocks tumbling.</a>
On Tuesday, Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) revealed it was notified by the Trump administration on April 9 that its H20 AI chip would now require an export license to be sold in China. The company warned that these tighter controls could slash its <a href="https://www.benzinga.com/government/regulations/25/04/44846329/nvidias-china-sales-face-setback-as-h20-chip-restrictions-catch-key-buyers-off-guard-reuters">earnings by $5.5 billion.</a>
Nvidia shares dropped 8.5% this week, erasing nearly half of the previous week&#8217;s gains. The broader semiconductor sector – as tracked by the iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) – followed suit, sliding 3% and logging its seventh weekly decline <a href="https://www.benzinga.com/general/health-care/25/04/44860240/unitedhealth-slashes-2025-outlook-on-medicare-funding-reductions-stock-crashes">out of the past eight.</a>
First-quarter earnings season delivered a mixed bag. While banks and streaming giant Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) showed solid performance, UnitedHealth Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) shocked investors by slashing its full-year guidance far below Wall Street expectations.
UnitedHealth shares plummeted 22.4% on Thursday, marking their worst one-day drop since 1998.
In trade news, Canada announced a six-month suspension of countermeasure tariffs on select U.S. goods essential for domestic manufacturing and food packaging. This move is expected to ease cross-border supply chain pressures, particularly<a href="https://www.benzinga.com/25/04/44816653/canada-eases-retaliatory-tariffs-on-us-goods-as-trade-tensions-thaw-under-softer-trump-stance-stocks-react"> benefiting Michigan-based automakers.</a>
On the macro front, Federal Reserve Chair Jerome Powell flagged inflation and growth risks stemming from trade tariffs, reiterating the Fed&#8217;s cautious stance and signaling that rate cuts <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44848474/fed-chair-powell-says-tariffs-lead-to-temporary-rise-in-inflation">won&#8217;t come prematurely.</a>
This cautious tone triggered an angry response from President Donald Trump, who blasted Powell as "always too late" on rate cuts and hinted at prematurely removing him from office, despite Powell's term <a href="https://www.benzinga.com/government/regulations/25/04/44862662/trump-pressures-fed-as-ecb-delivers-7th-straight-rate-cut">running through May 2026.</a>
Meanwhile, the European Central Bank executed its sixth consecutive rate cut, further fueling Trump's public frustration with the Fed. During an Oval Office meeting with Italian Prime Minister Giorgia Meloni, Trump doubled down, declaring that Powell &#8220;will be out <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44875406/hell-be-out-if-i-ask-him-can-trumps-threat-to-oust-powell-shake-the-fed">if the President asks.&#8221;</a>
Gold continues to defy gravity, fueled by strong investor demand, heightened policy uncertainty, and persistent central bank buying.
Bullion prices – as tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>) – soared to $3,330 per ounce, marking a new all-time high and extending gains to 14 of the past 16 weeks.
Read now: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44885051/netflix-beats-wall-street-forecasts-yet-goldman-sachs-sees-limited-upside-ahead">Netflix Beats Wall Street Forecasts, Yet Goldman Sachs Sees Limited Upside Ahead</a></li>
</ul>
Image: Shutterstock/Westlight

Earnings

Equities

Government

Large Cap

Macro Economic Events

Regulations

Broad U.S. Equity ETFs

Econ #s

Economics

Federal Reserve

Tech

ETFs

NVDA

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

Trump Blasts Powell, Nvidia Tumbles On New Export Ban, Gold Defies Gravity: This Week In Markets

Honeywell Intl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HON#NYSE">HON</a>) short percent of float has fallen 3.91% since its last report. The company recently reported that it has 7.90 million shares sold short, which is 1.23% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.79 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Honeywell Intl Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745002861_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Honeywell Intl has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Honeywell Intl's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Honeywell Intl's peer group average for short interest as a percentage of float is 6.43%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

What's Driving the Market Sentiment Around Honeywell Intl?

Adtalem Glb Education's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATGE#NYSE">ATGE</a>) short percent of float has risen 18.28% since its last report. The company recently reported that it has 1.18 million shares sold short, which is 4.53% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.06 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Adtalem Glb Education Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745002856_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Adtalem Glb Education has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Adtalem Glb Education's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Adtalem Glb Education's peer group average for short interest as a percentage of float is 4.09%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Adtalem Global Education Inc. Common Stock

ATGE

Is Adtalem Glb Education Gaining or Losing Market Support?

In the current market session, Paylocity Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCTY#NASDAQ">PCTY</a>) share price is at $183.98, after a 0.13% spike. Moreover, over the past month, the stock fell by 4.13%, but in the past year, went up by 15.31%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1745002829_0.png" alt="Past Year Chart" />

<h3>Evaluating Paylocity Holding P/E in Comparison to Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 53.5 in the Professional Services industry, Paylocity Holding Inc. has a lower P/E ratio of 47.24. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1745002829_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

PCTY

A Look Into Paylocity Holding Inc's Price Over Earnings

After months of sliding prices and bearish charts, <a href="https://www.benzinga.com/topic/oil">oil just pulled</a> a fast one. The United States Oil Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>) is up over 7% in the last five days &#8211; its best weekly move in months &#8211; raising the inevitable question: is the bottom finally in?
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0418"><img loading="lazy" decoding="async" width="627" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/18113256/Screenshot-2025-04-18-at-8.42.42-PM.png" alt="" class="wp-image-878296" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/18113256/Screenshot-2025-04-18-at-8.42.42-PM.png 627w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/18113256/Screenshot-2025-04-18-at-8.42.42-PM-300x234.png 300w" sizes="(max-width: 627px) 100vw, 627px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0418">Chart created using Benzinga Pro</a>
Technically speaking, the oil proxy, USO ETF still has a lot to prove. It's trading below its 20, 50, and 200-day simple moving averages (SMAs), flashing a bearish trend. On the yearly chart, the price is right below the 200-day SMA. If buying pressure and bullish momentum continues, we could see a major breakthrough above its long-term resistance.
Read Also: <a href="https://www.benzinga.com/news/global/25/04/44860334/china-cuts-us-oil-purchases-by-90-boosts-imports-from-canada-to-new-heights">China Slashes US Oil Imports By 90% Amid Trump Tariffs, Turns To Canada Instead</a>
That said, fundamentals are starting to shift &#8211; and smart money is sniffing opportunity. Energy investor Josh Young says we're seeing the "highest level of smart money buying oil since 2020."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&quot;highest level of smart money buying oil since 2020&quot; <a href="https://t.co/GuyQlekoax">https://t.co/GuyQlekoax</a>
&mdash; Josh Young (@Josh_Young_1) <a href="https://twitter.com/Josh_Young_1/status/1913061677907554644?ref_src=twsrc%5Etfw">April 18, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
And as Against All Odds Research bluntly put it: "Crude oil looks dead to most people. But commercials—the pros who live in this market—are quietly buying."
What&#8217;s driving the shift? Geopolitics and OPEC. U.S. sanctions on Chinese buyers of Iranian oil have added pressure to global supply, and deeper cuts from Iraq and Kazakhstan are tightening things further. Meanwhile, falling gasoline and distillate inventories suggest demand is still firm, despite a surprise crude stockpile build.
Sure, demand growth isn't what it used to be. Trade war fears and economic uncertainty still cloud the long-term picture. But right now, value buyers are stepping in—and the charts are finally reacting.
A bounce toward $75–$80 crude? Not out of the question. As long as key support levels hold, oil might just be setting up for a sneaky comeback.
In short: oil may not be pretty &#8211; but it's definitely not dead.
Read Next: 
<ul>
<li><a href="EXCLUSIVE: Tariff Uncertainty Turns Traders Cautious — But Oil, Silver Might Be The Escape Hatch, Says Market Analyst">EXCLUSIVE: Tariff Uncertainty Turns Traders Cautious — But Oil, Silver Might Be The Escape Hatch, Says Market Analyst</a></li>
</ul>
Image: Shutterstock/Andreas Vogel

Specialty ETFs

Technicals

Commodities

Oil's Not Dead Yet - Smart Money Thinks The Bottom's In

From the halls of Congress to the streets of New York, cannabis news bloomed in every direction this week. Slovenia introduced what may become Europe's most progressive medical cannabis law. U.S. lawmakers filed new federal reform legislation. Trulieve and Curaleaf took diverging paths in Florida. And Governor Ron DeSantis faces questions over whether public funds were funneled into anti-cannabis campaigns.
Elsewhere, Weedmaps dropped a custom sneaker collab, Swatch&#8217;s 4/20-friendly watch returned to the spotlight and a massive new cancer study delivered groundbreaking validation for medical cannabis. Avicanna posted record earnings, Minnesota crossed a regulatory milestone and Blue Violets made delivery history in New Jersey.
Here's everything you need to know.
<h3 class="wp-block-heading">Business And Financial Moves</h3>
Avicanna Reports Record Year
Avicanna Inc. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AVCN#TSX">AVCN</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/AVCNF#OTCQX">AVCNF</a>) reported audited financial results for 2024, including $25.5 million in revenue—a 52% increase over 2023—and gross profits of $12.9 million, up 94%. Consolidated gross margins improved to 51%, while adjusted EBITDA losses narrowed by 68% to $1.4 million. The company also repaid $1.3 million in debt.
CEO Aras Azadian called 2024 "our most successful year to date," citing clinical innovation, international expansion, and commercial growth in Canada and abroad.
Key 2024 milestones include:
<ul>
<li>A real-world evidence study in Canada evaluating cannabis for conditions like pain, sleep, anxiety and epilepsy</li>
<li>A completed study at The Hospital for Sick Children assessing CBD topical creams for wound healing</li>
<li>Drug approval in Colombia for Trunerox, targeting rare epileptic disorders</li>
<li>First delivery of CBD/CBG topicals to a multinational pharmaceutical company</li>
<li>Two new U.S. patents for topical and oral cannabinoid delivery technologies</li>
</ul>
<a href="https://www.benzinga.com/news/earnings/25/04/44802163/why-cannabis-focused-biopharma-co-avicanna-traded-up-26-today">Read the full story here</a>.
Tilray Plans Reverse Stock Split
Tilray Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) will hold a special shareholder meeting on June 10 to vote on a proposed reverse stock split ranging from 1-for-10 to 1-for-20. CEO Irwin Simon said the move aims to maintain Nasdaq compliance, reduce costs by more than $1 million per year, and attract institutional investors. The company recently reported over $248 million in cash and trimmed debt by $76 million.
<a href="https://www.benzinga.com/markets/cannabis/25/04/44871447/why-cannabis-co-tilray-tlry-is-trading-down-today">Read more on Benzinga</a>
Safe Harbor and FundCanna Join Forces
SHF Holdings, d/b/a Safe Harbor Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHFS#NASDAQ">SHFS</a>), announced a strategic partnership with FundCanna to provide cannabis operators with streamlined access to capital and compliant banking services. The agreement enables mutual referrals and onboarding of FundCanna-approved clients into Safe Harbor-managed accounts.
"This partnership delivers a practical, scalable solution that puts the financial needs of cannabis operators first," said Safe Harbor CEO Terry Mendez.
<h3 class="wp-block-heading">Politics, Policy And Regulation</h3>
Congress Reintroduces STATES 2.0 Act
A bipartisan group of U.S. lawmakers reintroduced the STATES 2.0 Act, which would shield legal cannabis activity from federal interference. The bill would also legalize interstate commerce, normalize IRS treatment of cannabis businesses and establish a framework for federal oversight and testing.
"The current federal approach to cannabis policy is not working," said Rep. Dave Joyce (R-OH), co-chair of the Congressional Cannabis Caucus. "The STATES 2.0 Act creates a more logical approach that protects states' rights while improving public safety."
The bill maintains FDA oversight for cannabis products, removes barriers to tax deductions under Section 280E, and instructs federal agencies to begin rulemaking within 180 days of passage. Supporters include Reps. Max Miller (R-OH), Dina Titus (D-NV) and a coalition of advocacy organizations including CPEAR, Americans for Prosperity, and the U.S. Cannabis Roundtable.
<a class="" href="https://www.marijuanamoment.net">Read more via Marijuana Moment</a>
Minnesota Finalizes Adult-Use Cannabis Rules
The Minnesota Office of Cannabis Management (OCM) announced that final adult-use rules were published in the State Register and are now in effect. With this step completed, OCM can begin issuing business licenses to qualifying applicants, including more than 600 social equity applicants already advanced through preapproval.
"We are continuing to prioritize social equity in every stage of licensing," said Jess Jackson, OCM's director of social equity. Licenses for capped categories such as cultivator and retailer will be awarded via lottery later this summer, while uncapped license types will be distributed on a rolling basis.
<a class="" href="https://cannabis.mn.gov">Details available on the OCM Rulemaking page</a>
Slovenia Unveils Progressive Medical Cannabis Law
Slovenia's Parliament introduced sweeping medical cannabis reforms that would legalize the cultivation, production and distribution of cannabis for medical and scientific use. The bill eliminates public tenders, allows open licensing for private companies and removes cannabis and THC from the country's prohibited drugs list—so long as products meet GACP, GMP and European Pharmacopeia standards.
Cannabis will be available via standard medical or veterinary prescriptions, and patient access is guaranteed through pharmacies, licensed distributors and healthcare providers.
The legislation follows a 2024 referendum in which 66.7% of voters supported cannabis cultivation and legalization for medical use. According to ICBC, the new framework would position Slovenia as having the most advanced medical cannabis law in Europe.
<a class="" href="https://internationalcbc.com/slovenian-parliament-introduces-europes-most-progressive-medical-cannabis-law">Full article via ICBC</a>
DeSantis Faces Scrutiny Over Anti-Cannabis Funding
A Miami Herald investigation revealed that the DeSantis administration steered $10 million from a legal Medicaid settlement to a charity led by Florida First Lady Casey DeSantis. That charity then gave $5 million each to two organizations backing a political committee that opposed Amendment 3, the failed 2024 initiative to legalize adult-use cannabis in Florida.
The money flowed from the Hope Florida Foundation to Secure Florida's Future and Save Our Society from Drugs, which then routed millions to Keep Florida Clean, a DeSantis-aligned committee. Republican lawmakers are now demanding records and investigating whether public funds were improperly used to fight cannabis legalization.
<a class="" href="https://www.miamiherald.com/news/politics-government/article304020886.html">Full investigation by the Miami Herald</a>
<h3 class="wp-block-heading">State Moves And Brand Power Plays</h3>
Carmelo Anthony Launches STAYME7O In New York
Carmelo Anthony has entered the New York cannabis market with STAYME7O, a premium cannabis brand launched in partnership with Grand National, the creative agency he co-founded with Jesce Horton and Brandon Drew Jordan Pierce. The product line features curated flower cultivated by Oregon-based LOWD, with an emphasis on sustainability and unique genetics.
"This isn't just about cannabis—it's about empowering our communities," Anthony said. A portion of proceeds will support NuProject and the Last Prisoner Project, continuing the brand's focus on economic equity and justice reform.
<a class="" href="https://www.benzinga.com/general/sports/25/04/44801792/carmelo-anthony-enters-new-york-cannabis-market-all-about-his-product-line-and-creative-agency">Full story on Benzinga</a>
Curaleaf Turns Dispensary Into Hemp Shop
Curaleaf (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) has converted one of its medical dispensaries in West Palm Beach into a hemp-focused retail store called The Hemp Company. The location will offer Farm Bill-compliant THC products from Curaleaf brands and partners like 1906 and Cann.
The move comes as Curaleaf distances itself from Florida's stalled adult-use push and signals short-term interest in the rapidly growing hemp-derived THC segment.
Trulieve Invests $19.6M To Revive Legalization Push
Trulieve (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) contributed $19.6 million to Smart &amp; Safe Florida to support another attempt at adult-use legalization in 2026. That's in addition to the $145 million the company spent on the failed 2024 initiative.
So far, only 150,804 signatures have been verified out of the 880,062 needed to qualify for the next ballot, raising questions about whether other operators will step in to help fund the campaign.
Herbwell Cannabis Targets Manhattan's Elite
Herbwell, a national cannabis chain, is opening a luxury dispensary at 519 Madison Avenue—possibly the only one of its kind on the high-end Manhattan corridor. The shop promises a curated experience for both seasoned users and curious first-timers.
"We've built a gorgeous dispensary that fits in on Madison Avenue," said CEO Arish Halani. "One day we'll be doing collabs with the biggest brands in the world."
The brand is also planning to open a cannabis club in the building's upper floors, including a rooftop lounge overlooking Midtown, pending future regulations.
New Jersey's First E-Bike Weed Delivery
Hoboken dispensary Blue Violets has launched New Jersey's first cannabis delivery service by e-bike, in partnership with delivery tech company Priscotty. The program is live in Hoboken and parts of Jersey City and Weehawken.
"We want to reach our customers when they can't make their way to the store—but in a way that makes sense," said Lauren Thompson, co-owner of Blue Violets.
<h3 class="wp-block-heading">Culture And Commentary</h3>
Mike Tyson Becomes CEO Of Carma HoldCo
Boxing legend Mike Tyson has taken the reins as CEO of Carma HoldCo, the company behind TYSON 2.0, Ric Flair Drip, Evol by Future and Wooooo! Energy. The move marks Tyson's shift from brand ambassador to active executive, steering a portfolio built on cultural storytelling and celebrity power.
"This isn't just a title—it's a responsibility I take seriously," Tyson said. Under his leadership, Carma plans to double down on authenticity, community engagement and global expansion.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44871633/mike-tyson-cannabis-ceo-the-champ-now-runs-carma-holdco">Read the full story on Benzinga</a>
Weedmaps Drops 420 1's Sneaker Collab With CEEZE
In one of the most buzzworthy 4/20 drops of the year, Weedmaps and custom sneaker studio CEEZE released the limited-edition "420 1's." Each of the 420 pairs is individually numbered, housed in an acrylic box with LED lighting and linked to a microsite via QR code.
The Friends &amp; Family version even includes GPS coordinates pointing to the historic San Francisco Cannabis Buyers Club. A sweepstakes is running through April 20, offering 20 pairs and one VIP trip to Spannabis.
<a class="" href="https://weedmaps.com/wm-sneakers-420-1s">Details and entry here</a>
Swatch's 4/20 Watch Gets a Second Life
Swatch's "Up In Smoke" watch from 2024 has found new life this April. With minty green hues, smoke-dial graphics and a laid-back BIOCERAMIC case, the piece fits right into the 4/20 aesthetic. Originally part of the BIG BOLD collection, the watch has quietly become a seasonal flex for cannabis aficionados.
<a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44878425/swatchs-up-in-smoke-watch-is-the-low-key-flex-of-4-20-season">Read the full feature on Benzinga</a>
Dreka Gates, Tiffany Haddish And Chamath Sound Off
Cannabis was also front and center in this week's cultural commentary. Highlights include:
<ul>
<li>Dreka Gates, in an exclusive interview, said: "Cannabis would be a trillion-dollar industry for Black and Brown communities—if it hadn't been criminalized." <a class="" href="https://www.benzinga.com/markets/cannabis/25/04/39798605/dreka-gates-cannabis-would-be-a-trillion-dollar-industry-for-black-and-brown-communities-if-it-h">Read more</a></li>
<li>Tiffany Haddish remarked that "If men had period pain, weed would already be legal." <a class="" href="https://www.benzinga.com/markets/cannabis/25/04/39797136/tiffany-haddish-if-men-had-period-pain-weed-would-already-be-legal">Full story here</a></li>
<li>Chamath Palihapitiya criticized the industry, saying legalization "turned our kids into zombies." <a class="" href="https://www.benzinga.com/general/health-care/25/04/44831042/chamath-palihapitiya-calls-for-mandate-on-insidious-marijuana-labelling-and-toxicity-says-its-turning-kids-into-zombies">His take here</a></li>
</ul>
<h3 class="wp-block-heading">Science And Health</h3>
Landmark Study Confirms Cannabis Benefits for Cancer Patients
In what may be the most comprehensive review of its kind, Cancer Playbook and the Whole Health Oncology Institute published a meta-analysis of over 10,000 peer-reviewed studies on medical cannabis and cancer. The result: a 3-to-1 scientific consensus in favor of cannabis for treating cancer-related symptoms, including inflammation, metastasis, appetite loss and pain.
"We expected controversy. What we found was overwhelming scientific consensus," said Ryan Castle, WHOI's head of research.
The study also incorporated patient-reported outcomes to highlight real-world effectiveness—marking a shift toward more holistic, experience-driven research models. Findings from this report were submitted to the DEA as part of the case for rescheduling cannabis.
<a class="" href="https://www.benzinga.com/general/health-care/25/04/44835610/game-changing-study-confirms-medical-cannabis-helps-cancer-patients-we-found-overwhelming-scientific-consensus">Link to the full Benzinga article</a>
Israel Slaps 165% Tariffs on Canadian Cannabis
In a dramatic turn, Israel's Ministry of Economy announced it will impose tariffs of up to 165% on Canadian cannabis imports for the next four years. The decision—pending approval by the Knesset Finance Committee—carves out exceptions for select producers like Decibel (12%), Village Farms (28%), Organigram (53%) and Tilray (70%).
The move signals a potential realignment of the global cannabis trade, with implications for both exporters and Israeli medical patients.
<a class="" href="https://stratcann.com">More via StratCann</a>
<h3 class="wp-block-heading">Recommended Reads</h3>
<ul>
<li><a class="" href="https://www.forbes.com/sites/javierhasse/2025/04/14/he-sold-his-cannabis-vape-brand-for-nine-figures-now-hes-coming-for-your-cocktail/">He Sold His Cannabis Vape Brand for Nine Figures—Now He's Coming for Your Cocktail</a></li>
<li><a class="" href="https://www.benzinga.com/markets/cannabis/25/04/44818968/how-one-european-company-is-flooding-america-with-cannabis-seeds">How One European Company Is Flooding America With Cannabis Seeds</a></li>
</ul>
That&#8217;s it for this week. See you next Friday!

General

AVCNF

SHF Holdings, Inc. - Class A Common Stock

SHFS

TCNNF

TSX:AVCN

This Week In Cannabis: Carmelo's NY Launch, Federal Reform, Cancer Study, Avicanna's Growth, Tilray's Split, DeSantis Fallout, Slovenia's Big Move And More

<a href="https://www.wsj.com/business/autos/china-ford-halts-shipment-3cb51285?msockid=21c662101c496b42343370ae1de86aaa">https://www.wsj.com/business/autos/china-ford-halts-shipment-3cb51285?msockid=21c662101c496b42343370ae1de86aaa</a>

'Ford Halts Shipments of F-150s and Other Models to China'- WSJ

Press Releases

Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX Trial

Lisata Therapeutics to Present at the 2025 Sequire Investor Summit

Lisata Therapeutics Reports Encouraging Preliminary Cohort A Data from the AGITG-led Phase 2 ASCEND Trial Evaluating Certepetide with Standard-of-Care Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma

Health Care

Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal Adenocarcinoma

Comments

Lisata Therapeutics

Lisata Therapeutics (LSTA) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL